Ligne 3 : |
Ligne 3 : |
| <ref>https://www.facebook.com/onlymefoundation/posts/dr-jack-lambert-is-a-scottish-doctor-who-is-currently-working-as-an-infectious-d/1294963953940812/ [Traduction DeepL du début du post:<br>Le Dr Jack Lambert est un médecin écossais qui travaille actuellement en tant que consultant en maladies infectieuses dans un hôpital public de Dublin, en Irlande. Il a commencé à traiter des patients atteints de la borréliose de Lyme il y a 20 ans aux États-Unis et au cours des 5 dernières années en Irlande.<br>Il a également traité avec succès un certain nombre de jeunes femmes qui sont tombées malades après avoir été vaccinées contre le VPH [Virus du papillome humain], ce qui semble avoir stimulé la réactivation d'une infection latente de Lyme.<br>[...] </ref> | | <ref>https://www.facebook.com/onlymefoundation/posts/dr-jack-lambert-is-a-scottish-doctor-who-is-currently-working-as-an-infectious-d/1294963953940812/ [Traduction DeepL du début du post:<br>Le Dr Jack Lambert est un médecin écossais qui travaille actuellement en tant que consultant en maladies infectieuses dans un hôpital public de Dublin, en Irlande. Il a commencé à traiter des patients atteints de la borréliose de Lyme il y a 20 ans aux États-Unis et au cours des 5 dernières années en Irlande.<br>Il a également traité avec succès un certain nombre de jeunes femmes qui sont tombées malades après avoir été vaccinées contre le VPH [Virus du papillome humain], ce qui semble avoir stimulé la réactivation d'une infection latente de Lyme.<br>[...] </ref> |
| | | |
− | Sur PubMed, il est John S. Lambert, mais il se fait aussi appeler John (Jack) Lambert et Jack (John) Lambert ou tout simplement John Lambert<ref>https://lymediseaseuk.com/2017/12/19/dr-john-lambert-expert-qa-video/ (lien mort)</ref> ou Jack Lambert.<ref>http://www.visavissymposiums.org/symposiums-2/tick-borne-disease-symposium-2016/</ref> Il intervient sur la [[Maladie de Lyme|Borréliose de Lyme]], à la fois en Ecosse, au Royaume-Uni et en Irlande, depuis au moins 2016, promouvant les thèses et recommandations de l'[[ILADS]]. | + | Sur PubMed il est John S. Lambert, mais il se fait aussi appeler John (Jack) Lambert<ref>https://www.lymeresourcecentre.com/about-us/jlambert Présentation de John (Jack) Lambert sur le site web du LRC (Lyme Research Center). [Traduction DeepL: ]<br>Notre administrateur principal, le professeur John (Jack) Lambert, est professeur de médecine et de maladies infectieuses à l'hôpital universitaire Mater Misericordiae et à la faculté de médecine de l'UCD, à Dublin, et possède une vaste expérience clinique et de recherche.<br><br>Il a été directeur de l'unité nationale d'isolement pour les maladies hautement infectieuses à l'hôpital universitaire Mater Misericordiae et membre du comité national de la fièvre hémorragique virale du HSE. Il a également été impliqué dans le groupe de stratégie de santé sexuelle en Irlande et a enseigné aux médecins généralistes d'Irlande le sujet des MST [Maladies Sexuellement Transmissibles]. Il est membre du Royal College of Paediatrics and Child Health depuis 2000 et du Royal College of Physicians depuis 2005.<br><br>Il a fait de nombreuses présentations dans le domaine de Lyme et des co-infections depuis 2016 dans le cadre de conférences européennes et américaines soutenues par l'[[ILADS|International Lyme and Associated Diseases Society (ILADS)]]. Il a suivi une formation spécialisée par le biais de l'[[ILADS]] et possède une expérience significative dans le traitement de la [[maladie de Lyme]] et des co-infections.<br><br>Il a organisé et dirigé les 1ère et 2ème Conférences européennes sur les Crypto-Infections, portant sur la science derrière la [[maladie de Lyme]] et les co-infections, qui se sont tenues à Dublin en mai 2019 et en ligne en septembre 2020.</ref> et Jack (John) Lambert ou tout simplement John Lambert<ref>https://lymediseaseuk.com/2017/12/19/dr-john-lambert-expert-qa-video/ (lien mort)</ref> ou Jack Lambert<ref>http://www.visavissymposiums.org/symposiums-2/tick-borne-disease-symposium-2016/</ref>. Il intervient sur la [[Maladie de Lyme|Borréliose de Lyme]], à la fois en Ecosse, au Royaume-Uni et en Irlande, depuis au moins 2016, promouvant les thèses et recommandations de l'[[ILADS]]. |
| + | |
| + | John S. Lambert est le fondateur, en 2019, du LRC (Lyme Resource Centre), "''une organisation caritative basée au Royaume-Uni dont la mission est d'informer le public et les professionnels de la santé sur la maladie de Lyme et les co-infections transmises par les tiques, et de collaborer avec d'autres pour rechercher des moyens de lutter contre toutes les maladies transmises par les tiques''", et son administrateur principal.<ref>https://www.lymeresourcecentre.com/who-we-are <br>The Lyme Resource Centre is a charity based in the UK with a mission to educate the public and healthcare professionals about Lyme disease and related tick-borne co-infections and work with others to research ways to combat all tick-borne illnesses.</ref> |
| | | |
| <ref>ILADS_BOSTON_2017-Dr-LAMBERT.pdf <br>[Traduction DeepL de l'Abstract:]<br>Résumé:<br>L'"expérience irlandaise" n'est pas unique et constitue probablement un "instantané" des autres pays de l'UE.<br>- La surveillance et les rapports actuels sont inadéquats.<br>- Les tests d'anticorps actuels, qui constituent la "norme d'excellence", passent à côté de nombreux patients.<br>- La découverte, dans le cas d'un anticorps de lyme négatif, d'un anticorps positif contre l'anaplasme, la babésia ou les rickettsies, signifie une infection antérieure ou actuelle par une infection transmise par les tiques, probablement aussi par Borrelia.<br>- Les "tests allemands", très décriés par les spécialistes de l'identification en Irlande, représentent un outil supplémentaire pour identifier une co-infection lorsque les autres "tests standard" n'ont pas permis de poser le diagnostic.<br>- Certains consultants ne veulent pas reconsidérer leur diagnostic, même lorsque l'état des patients s'améliore avec le traitement.</ref> | | <ref>ILADS_BOSTON_2017-Dr-LAMBERT.pdf <br>[Traduction DeepL de l'Abstract:]<br>Résumé:<br>L'"expérience irlandaise" n'est pas unique et constitue probablement un "instantané" des autres pays de l'UE.<br>- La surveillance et les rapports actuels sont inadéquats.<br>- Les tests d'anticorps actuels, qui constituent la "norme d'excellence", passent à côté de nombreux patients.<br>- La découverte, dans le cas d'un anticorps de lyme négatif, d'un anticorps positif contre l'anaplasme, la babésia ou les rickettsies, signifie une infection antérieure ou actuelle par une infection transmise par les tiques, probablement aussi par Borrelia.<br>- Les "tests allemands", très décriés par les spécialistes de l'identification en Irlande, représentent un outil supplémentaire pour identifier une co-infection lorsque les autres "tests standard" n'ont pas permis de poser le diagnostic.<br>- Certains consultants ne veulent pas reconsidérer leur diagnostic, même lorsque l'état des patients s'améliore avec le traitement.</ref> |
| | | |
| == Biographie de John Lambert sur le site du Mater Hospital de Dublin == | | == Biographie de John Lambert sur le site du Mater Hospital de Dublin == |
− | [Traduction DeepL: ]<br>Le Dr John Lambert est consultant en maladies infectieuses et en médecine génito-urinaire. Il exerce à Dublin, en Irlande, en tant que consultant à l'hôpital universitaire Mater Misericordiae et à la maternité Rotunda, et enseigne à l'école de médecine et de sciences médicales de l'UCD [University College Dublin]. Il est directeur de l'unité nationale d'isolement pour les maladies hautement infectieuses à l'hôpital universitaire Mater Misericordiae et membre du comité national de la fièvre hémorragique virale du HSE. Il a également été impliqué dans le groupe de stratégie de santé sexuelle en Irlande et a enseigné aux médecins généralistes irlandais sur le sujet des MST [Maladies Sexuelles Transmissibles]. Il a été formé aux États-Unis, à l'Université d'État du Michigan et à Rochester NY, et a été professeur adjoint à l'Institut de virologie humaine de Johns Hopkins et de l'Université du Maryland à Baltimore avant de retourner au Royaume-Uni en 2000, où il a travaillé au St Mary's and Kings College Hospital de 2000 à 2005 avant sa nomination à Dublin. Ses travaux sur le VIH se sont concentrés sur l'étude des médicaments anti-VIH et sur la coi-nfection par le VIH et l'hépatite C. Il s'est également intéressé à l'infection par le VIH pendant la grossesse et aux études sur la surveillance des médicaments thérapeutiques pendant la grossesse. Il a rédigé plus de 10 chapitres de livres et 80 articles évalués par des pairs, principalement sur les maladies infectieuses, les vaccins, le VIH et les MST [Maladies sexuelles transmissibles].<ref>https://www.mater.ie/consultants/dr-john-lambert/ Biography<br>Dr John Lambert is is a consultant in Infectious diseases and genitourinary medicine, and has been practicing in Dublin Ireland as a consultant in the Mater Misericordiae University Hospital and Rotunda Maternity hospitals, with teaching appointment at UCD School of Medicine and Medical Science. He is director of the National Isolation Unit for Highly Infectious Diseases at the Mater Misericordiae University Hospital and a member of the National Viral Hemorrhagic Fever Committee of the HSE. He has also been involved in the Sexual Health Strategy group in Ireland and teaching GP in Ireland on the subject of STDs. His training was in the USA at Michigan State University and Rochester NY, and he was an assistant professor at Johns Hopkins and University of Maryland Institute of Human Virology in Baltimore prior to returning to the UK in 2000, where we worked at St Mary’s and Kings College Hospital 2000-2005 prior to his appointment in Dublin. His HIV work has focused on HIV drugs studies and HIV and hepatitis C coinfection studies, and he has been active in HIV infection in pregnancy and studies of therapeutic drug monitoring in pregnancy. He has over 10 book chapters and 80 peer reviewed articles, primarily on infectious diseases, vaccines, HIV and STDs.</ref> | + | [Traduction DeepL: ]<br>Le Dr John Lambert est consultant en maladies infectieuses et en médecine génito-urinaire. Il exerce à Dublin, en Irlande, en tant que consultant à l'hôpital universitaire Mater Misericordiae et à la maternité Rotunda, et enseigne à l'école de médecine et de sciences médicales de l'UCD [University College Dublin]. Il est directeur de l'unité nationale d'isolement pour les maladies hautement infectieuses à l'hôpital universitaire Mater Misericordiae et membre du comité national de la fièvre hémorragique virale du HSE. Il a également été impliqué dans le groupe de stratégie de santé sexuelle en Irlande et a enseigné aux médecins généralistes irlandais sur le sujet des MST [Maladies Sexuelles Transmissibles]. Il a été formé aux États-Unis, à l'Université d'État du Michigan et à Rochester NY, et a été professeur adjoint à l'Institut de virologie humaine de Johns Hopkins et de l'Université du Maryland à Baltimore avant de retourner au Royaume-Uni en 2000, où il a travaillé au St Mary's and Kings College Hospital de 2000 à 2005 avant sa nomination à Dublin. Ses travaux sur le VIH se sont concentrés sur l'étude des médicaments anti-VIH et sur la coi-nfection par le VIH et l'hépatite C. Il s'est également intéressé à l'infection par le VIH pendant la grossesse et aux études sur la surveillance des médicaments thérapeutiques pendant la grossesse. Il a rédigé plus de 10 chapitres de livres et 80 articles évalués par des pairs, principalement sur les maladies infectieuses, les vaccins, le VIH et les MST [Maladies sexuelles transmissibles].<ref>https://www.mater.ie/consultants/dr-john-lambert/ Biography<br>Dr John Lambert is a consultant in Infectious diseases and genitourinary medicine, and has been practicing in Dublin Ireland as a consultant in the Mater Misericordiae University Hospital and Rotunda Maternity hospitals, with teaching appointment at UCD School of Medicine and Medical Science. He is director of the National Isolation Unit for Highly Infectious Diseases at the Mater Misericordiae University Hospital and a member of the National Viral Hemorrhagic Fever Committee of the HSE. He has also been involved in the Sexual Health Strategy group in Ireland and teaching GP in Ireland on the subject of STDs. His training was in the USA at Michigan State University and Rochester NY, and he was an assistant professor at Johns Hopkins and University of Maryland Institute of Human Virology in Baltimore prior to returning to the UK in 2000, where we worked at St Mary’s and Kings College Hospital 2000-2005 prior to his appointment in Dublin. His HIV work has focused on HIV drugs studies and HIV and hepatitis C coinfection studies, and he has been active in HIV infection in pregnancy and studies of therapeutic drug monitoring in pregnancy. He has over 10 book chapters and 80 peer reviewed articles, primarily on infectious diseases, vaccines, HIV and STDs.</ref> |
| | | |
− | == Implication de John S. Lambert dans la demande de révision des codes CIM pour la Borreliose de Lyme à l'OMS == | + | == John S. Lambert demande la révision des codes CIM-11 pour la Borreliose de Lyme à l'OMS == |
| [[Jenna Luché-Thayer]], directrice du comité ad hoc, a donné un aperçu du rapport 2018 « La situation des défenseurs des droits humains de Lyme et des patients atteints de borréliose de la fièvre récurrente », qui a été suivi par des représentants partageant des cas de leurs pays. [...] Le professeur français [[FFMVT|Christian Perronne]] est un spécialiste des maladies infectieuses et tropicales de renommée internationale avec [Psiram.com: soi-disant] plus de 300 publications scientifiques et a joué un rôle consultatif auprès de l'OMS. [[FFMVT|Perronne]] a expliqué au Rapporteur spécial comment, à la suite de sa présentation de 2016 sur la LB à l'Académie nationale de médecine de France, il a été publiquement qualifié de « terroriste » par l'ancien président de l'Académie, le professeur Marc Gentilini. [...]<ref>https://canlyme.com/2018/06/14/corruption-and-human-rights-violations-against-lyme-doctors-scientists-and-parents-now-on-united-nations-record/</ref> | | [[Jenna Luché-Thayer]], directrice du comité ad hoc, a donné un aperçu du rapport 2018 « La situation des défenseurs des droits humains de Lyme et des patients atteints de borréliose de la fièvre récurrente », qui a été suivi par des représentants partageant des cas de leurs pays. [...] Le professeur français [[FFMVT|Christian Perronne]] est un spécialiste des maladies infectieuses et tropicales de renommée internationale avec [Psiram.com: soi-disant] plus de 300 publications scientifiques et a joué un rôle consultatif auprès de l'OMS. [[FFMVT|Perronne]] a expliqué au Rapporteur spécial comment, à la suite de sa présentation de 2016 sur la LB à l'Académie nationale de médecine de France, il a été publiquement qualifié de « terroriste » par l'ancien président de l'Académie, le professeur Marc Gentilini. [...]<ref>https://canlyme.com/2018/06/14/corruption-and-human-rights-violations-against-lyme-doctors-scientists-and-parents-now-on-united-nations-record/</ref> |
| | | |
Ligne 59 : |
Ligne 61 : |
| John Lambert en est l'administrateur principal (pour la médecine)<ref>http://www.visavissymposiums.org/patrons/</ref>. | | John Lambert en est l'administrateur principal (pour la médecine)<ref>http://www.visavissymposiums.org/patrons/</ref>. |
| | | |
− | === Le symposium Vis-à-Vis du 7 juin 2014 à Londres === | + | === Le symposium Vis-a-Vis du 7 juin 2014 à Londres === |
| Les orateurs étaient: | | Les orateurs étaient: |
| * '''The Countess of Mar'''<br>Margaret of Mar is the 31st Countess of Mar, our oldest peerage, and has been a member of the House of Lords since 1975. When the House of Lords act was passed in 1999 to restrict the number of hereditary peers Lady Mar was elected to the new House receiving the highest number of votes in support. [...] | | * '''The Countess of Mar'''<br>Margaret of Mar is the 31st Countess of Mar, our oldest peerage, and has been a member of the House of Lords since 1975. When the House of Lords act was passed in 1999 to restrict the number of hereditary peers Lady Mar was elected to the new House receiving the highest number of votes in support. [...] |
Ligne 70 : |
Ligne 72 : |
| * '''Dr [[Steven Bock]]''' <br>'''30 years practicing complementary and progressive medicine. A clinical instructor of Family Medicine at Albany Medical College (USA) and the New York Medical College.'''<br>Functional medicine in the service of the diagnosis and treatment of Tick-Borne diseases, with emphasis on immune support, GI health, detoxification, heavy metal reduction, herbal medicine and alternative therapies including ondamed, acupuncture, IV nutritional therapy and other important supportive modalities. <ref>http://www.visavissymposiums.org/symposiums-2/symposiums/</ref> | | * '''Dr [[Steven Bock]]''' <br>'''30 years practicing complementary and progressive medicine. A clinical instructor of Family Medicine at Albany Medical College (USA) and the New York Medical College.'''<br>Functional medicine in the service of the diagnosis and treatment of Tick-Borne diseases, with emphasis on immune support, GI health, detoxification, heavy metal reduction, herbal medicine and alternative therapies including ondamed, acupuncture, IV nutritional therapy and other important supportive modalities. <ref>http://www.visavissymposiums.org/symposiums-2/symposiums/</ref> |
| | | |
− | === Le Symposium Vis-à-Vis du 1er octobre 2016 à Londres === | + | === Le Symposium Vis-a-Vis du 1er octobre 2016 à Londres === |
| Il n'existe pour avoir quelques informations à son sujet qu'une affiche publicitaire<ref>https://webcache.googleusercontent.com/search?q=cache:p3r033fLa08J:www.visavissymposiums.org/symposiums-2/tick-borne-disease-symposium-2016/</ref> | | Il n'existe pour avoir quelques informations à son sujet qu'une affiche publicitaire<ref>https://webcache.googleusercontent.com/search?q=cache:p3r033fLa08J:www.visavissymposiums.org/symposiums-2/tick-borne-disease-symposium-2016/</ref> |
| | | |
Ligne 96 : |
Ligne 98 : |
| This symposium is supported by Vis-a-Vis symposiums - A Registered Charity.<ref>http://www.visavissymposiums.org/symposiums-2/tick-borne-disease-symposium-2016/</ref> | | This symposium is supported by Vis-a-Vis symposiums - A Registered Charity.<ref>http://www.visavissymposiums.org/symposiums-2/tick-borne-disease-symposium-2016/</ref> |
| | | |
− | === Le Symposium Vis-à-Vis du 6 juillet 2018 à Londres === | + | === Le Symposium Vis-a-Vis du 6 juillet 2018 à Londres === |
| Il a eu lieu à l'Imperial College Medical School, St. Mary's Hospital Campus, London.<br>Thème du symposium: '''Lyme Disease in th UK - Epidemiology, Diagnostic and Management''' | | Il a eu lieu à l'Imperial College Medical School, St. Mary's Hospital Campus, London.<br>Thème du symposium: '''Lyme Disease in th UK - Epidemiology, Diagnostic and Management''' |
| | | |
Ligne 150 : |
Ligne 152 : |
| | | |
| === La "Lyme Disease Conférence" de 2017 en Irlande === | | === La "Lyme Disease Conférence" de 2017 en Irlande === |
− | <ref>https://www.youtube.com/watch?v=bSvYVIIo7TQ Tick Talk Ireland, 2017 Irish Lyme Disease Conference - Nicci St George Smith</ref> | + | Titre de la vidéo youtube "Tick Talk Ireland, 2017 Irish Lyme Disease Conference - Nicci St George Smith". Durée 21:44. <ref>https://www.youtube.com/watch?v=bSvYVIIo7TQ Tick Talk Ireland, 2017 Irish Lyme Disease Conference - Nicci St George Smith</ref> |
| | | |
− | == Participation de John S. Lambert à la conférence ILADSEUROPE2017 co-organisée par Christian Perronne à Paris == | + | == Participation de John S. Lambert à la conférence ILADSEUROPE2017 co-organisée par [[Christian Perronne]] à Paris == |
| Cette conférence a eu lieu les vendredi 17 et samedi 18 mars 2017.<br>John S. Lambert a fait une conférence le 17 mars de 8h45 à 9h25 : Conférence scientifique (salle Vendôme): Lyme et co-infections : l'expérience irlandaise<br>Puis, il a animé un groupe de 13h30 à 14h00 (salle Vendôme) : Sélection de résumés oraux.<ref>https://ww2.eventrebels.com/er/CFP/AgendaAtAGlance.jsp?CFPID=690&ScreenID=326&Token=HCMTJS4F6 Programme de la conférence ILADSEUROPE2017</ref> | | Cette conférence a eu lieu les vendredi 17 et samedi 18 mars 2017.<br>John S. Lambert a fait une conférence le 17 mars de 8h45 à 9h25 : Conférence scientifique (salle Vendôme): Lyme et co-infections : l'expérience irlandaise<br>Puis, il a animé un groupe de 13h30 à 14h00 (salle Vendôme) : Sélection de résumés oraux.<ref>https://ww2.eventrebels.com/er/CFP/AgendaAtAGlance.jsp?CFPID=690&ScreenID=326&Token=HCMTJS4F6 Programme de la conférence ILADSEUROPE2017</ref> |
| | | |
Ligne 233 : |
Ligne 235 : |
| ''Expert in Translational Medicine, the science and art of advancing medical science safely and efficiently'' | | ''Expert in Translational Medicine, the science and art of advancing medical science safely and efficiently'' |
| | | |
− | Dr. Mozayeni trained in Internal Medicine, Rheumatology and Molecular Biophysics in a physician-scientist research residency at Yale-New Haven Hospital, where Lyme disease was discovered and treated by Rheumatologists in the Rheumatology section. He subsequently became a Senior Staff Fellow at the National Institutes of Health (NIH) where he completed a second fellowship in Rheumatology. Since 1994, while in private practice, has held clinical privileges at Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the NIH Clinical Center.<br>Recently, he became the President of [[ILADS]]. His main objective with [[ILADS]] is the same as with his professional career – to advance the science of translational medicine and learn from the issues presented by Lyme disease, how to more rapidly advance medical science. His career passion is to find the fastest path for advancing medical science in diverse areas of patient need and controversy to validate and continuously improve best clinical practices.<br>He is the Chief Medical Officer of Galaxy Diagnostics, LLC. Recently, he founded ‘T Lab’ focusing on the use of high resolution microscopy to identify cryptic infections and demonstrate how they cause disease. He is a Fellow of the non-profit Think Lead Innovate Foundation and he is a founder of the non-profit Foundation for the Study of Inflammatory Diseases.<br>His work on cerebrovascular diseases, as a Rheumatologist, he began to appreciate the importance of Bartonella cryptic infections. Over the past 12 years, he has been actively researching chronic rheumatic and cerebrovascular diseases and their relationship to persistent human Bartonella infection. | + | Dr. Mozayeni trained in Internal Medicine, Rheumatology and Molecular Biophysics in a physician-scientist research residency at Yale-New Haven Hospital, where Lyme disease was discovered and treated by Rheumatologists in the Rheumatology section. He subsequently became a Senior Staff Fellow at the National Institutes of Health (NIH) where he completed a second fellowship in Rheumatology. Since 1994, while in private practice, has held clinical privileges at Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the NIH Clinical Center.<br>Recently, he became the President of [[ILADS]] (2019-2021). His main objective with [[ILADS]] is the same as with his professional career – to advance the science of translational medicine and learn from the issues presented by Lyme disease, how to more rapidly advance medical science. His career passion is to find the fastest path for advancing medical science in diverse areas of patient need and controversy to validate and continuously improve best clinical practices.<br>He is the Chief Medical Officer of Galaxy Diagnostics, LLC. Recently, he founded ‘T Lab’ focusing on the use of high resolution microscopy to identify cryptic infections and demonstrate how they cause disease. He is a Fellow of the non-profit Think Lead Innovate Foundation and he is a founder of the non-profit Foundation for the Study of Inflammatory Diseases.<br>His work on cerebrovascular diseases, as a Rheumatologist, he began to appreciate the importance of Bartonella cryptic infections. Over the past 12 years, he has been actively researching chronic rheumatic and cerebrovascular diseases and their relationship to persistent human Bartonella infection. |
| | | |
| ==== Dr. [[Natasha Rudenko]], PhD. ==== | | ==== Dr. [[Natasha Rudenko]], PhD. ==== |
Ligne 243 : |
Ligne 245 : |
| ''Professor of Infectious and Tropical Diseases at the University of Versailles-St Quentin (UVSQ), France'' | | ''Professor of Infectious and Tropical Diseases at the University of Versailles-St Quentin (UVSQ), France'' |
| | | |
− | Christian Perronne, MD, PhD, qualified in Internal medicine, is Professor of Infectious and Tropical Diseases at the University of Versailles-St Quentin (UVSQ), Paris-Saclay, France. Since 1994, he is chief of a Department of Medicine at the Raymond Poincaré University Hospital in Garches, Greater Paris University Hospitals group. He had major responsibilities within several institutions: Pasteur institute in Paris (vice-director of the national tuberculosis reference center), French College of Professors of Infectious and Tropical Diseases (chairman), French National Technical Advisory Group of Experts on Immunisation (chairman), French Drug Agency (chairman of several working groups making evidence based recommendations), Superior Council for Public Hygiene of France (Chairman), French High Council for Public Health (Chairman of the Communicable diseases commission), INSERM, National Council of Universities (Chairman for infectious and tropical diseases), European Advisory Group of Experts on Immunisation at the World Health Organization (vice-chairman). He was principal investigator of several major clinical trials. He is author or co-author of more than 300 scientific publications in peer-reviewed journals. Since 1994, Christian Perronne is involved in the management of chronic Lyme and associated diseases. He is leading a coalition of patients and physicians for the recognition of chronic Lyme disease and other crypto-infections (hidden infections) in France. He is cofounder and vice-president of the French federation against tick-borne diseases (FFMVT) and president of its scientific council. He is author of a book “La vérité sur la maladie de Lyme” (in French) (“The truth about Lyme disease”), Odile Jacob publisher, Paris, which will be published in English in May 2020 (“Crypto-infection, the truth about Lyme disease and other hidden infections”), Hammersmith publisher, London, Dublin. | + | Christian Perronne, MD, PhD, qualified in Internal medicine, is Professor of Infectious and Tropical Diseases at the University of Versailles-St Quentin (UVSQ), Paris-Saclay, France. Since 1994, he is chief of a Department of Medicine at the Raymond Poincaré University Hospital in Garches, Greater Paris University Hospitals group. He had major responsibilities within several institutions: Pasteur institute in Paris (vice-director of the national tuberculosis reference center), French College of Professors of Infectious and Tropical Diseases (chairman), French National Technical Advisory Group of Experts on Immunisation (chairman), French Drug Agency (chairman of several working groups making evidence based recommendations), Superior Council for Public Hygiene of France (Chairman), French High Council for Public Health (Chairman of the Communicable diseases commission), INSERM, National Council of Universities (Chairman for infectious and tropical diseases), European Advisory Group of Experts on Immunisation at the World Health Organization (vice-chairman). He was principal investigator of several major clinical trials. He is author or co-author of more than 300 scientific publications in peer-reviewed journals. Since 1994, Christian Perronne is involved in the management of chronic Lyme and associated diseases. He is leading a coalition of patients and physicians for the recognition of chronic Lyme disease and other crypto-infections (hidden infections) in France. He is cofounder and vice-president of the [[FFMVT|French federation against tick-borne diseases (FFMVT)]] and president of its scientific council. He is author of a book “La vérité sur la maladie de Lyme” (in French) (“The truth about Lyme disease”), Odile Jacob publisher, Paris, which will be published in English in May 2020 (“Crypto-infection, the truth about Lyme disease and other hidden infections”), Hammersmith publisher, London, Dublin. |
| | | |
− | ==== Dr Alain Trautmann ==== | + | |
| + | ====Dr Alain Trautmann==== |
| ''Emeritus researcher, Cochin Institute, Paris, France'' | | ''Emeritus researcher, Cochin Institute, Paris, France'' |
| | | |
| Alain Trautmann is an emeritus researcher form CNRS. He has been working first in neurobiology, then in immunology. Still active in cancer immunotherapy at the Cochin Institute in Paris, he became interested in Lyme disease for family reasons a few years ago. He is member of the scientific advisory board of FFMVT, the French federation of tick-borne diseases | | Alain Trautmann is an emeritus researcher form CNRS. He has been working first in neurobiology, then in immunology. Still active in cancer immunotherapy at the Cochin Institute in Paris, he became interested in Lyme disease for family reasons a few years ago. He is member of the scientific advisory board of FFMVT, the French federation of tick-borne diseases |
| | | |
− | ==== Dr Hugues Gascan ==== | + | ====Dr Hugues Gascan==== |
| ''Research Director at CNRS (French National Centre for Scientific Research), IGDR, Rennes and Angers, France'' | | ''Research Director at CNRS (French National Centre for Scientific Research), IGDR, Rennes and Angers, France'' |
| | | |
| Hugues Gascan is a research director from CNRS, the French National Centre for Scientific Research, and he has been working in the field of immunology, and more particularly in cytokines and chronic diseases for approximately 35 years. He has been interested in Lyme disease for few years now, leading a project whose aim is an analysis of the immune response in late and chronic forms of this pathology, in order to facilitate its diagnosis. | | Hugues Gascan is a research director from CNRS, the French National Centre for Scientific Research, and he has been working in the field of immunology, and more particularly in cytokines and chronic diseases for approximately 35 years. He has been interested in Lyme disease for few years now, leading a project whose aim is an analysis of the immune response in late and chronic forms of this pathology, in order to facilitate its diagnosis. |
| | | |
− | ==== Stefan Linder ==== | + | ====Stefan Linder==== |
| ''Professor for Cellular Microbiology, University Medical Center Eppendorf, 20246 Hamburg, Germany'' | | ''Professor for Cellular Microbiology, University Medical Center Eppendorf, 20246 Hamburg, Germany'' |
| | | |
| Stefan Linder holds a professorship for Cellular Microbiology at the University of Hamburg since 2009. His research is focused on the interaction between bacterial pathogens and human immune cells, and specifically on the uptake and intracellular processing of Borrelia burgdorferi by primary human macrophages. His group is particularly interested in the regulation of cytoskeletal dynamics and intracellular trafficking pathways that contribute to phagocytosis and phagolysosomal degradation of borreliae. | | Stefan Linder holds a professorship for Cellular Microbiology at the University of Hamburg since 2009. His research is focused on the interaction between bacterial pathogens and human immune cells, and specifically on the uptake and intracellular processing of Borrelia burgdorferi by primary human macrophages. His group is particularly interested in the regulation of cytoskeletal dynamics and intracellular trafficking pathways that contribute to phagocytosis and phagolysosomal degradation of borreliae. |
| | | |
− | ==== Dr Cheryl Stroud, DVM, PhD ==== | + | ====Dr Cheryl Stroud, DVM, PhD ==== |
| ''One Health Commission, USA'' | | ''One Health Commission, USA'' |
| | | |
Ligne 267 : |
Ligne 270 : |
| Currently as Executive Director of the One Health Commission Dr. Stroud’s primary focus is educating, locally, nationally and globally, about the need for One Health when addressing issues like vector-borne diseases. She shares updates about the global One Health movement with audiences around the world and seeks to connect One Health stakeholders into Action Teams, strategic networks and partnerships that educate about the full scope of and critical need for One Health thinking and acting at all levels of academia, research, clinical practice and government. She refers to One Health as our ‘Ray of Hope for the Future’. | | Currently as Executive Director of the One Health Commission Dr. Stroud’s primary focus is educating, locally, nationally and globally, about the need for One Health when addressing issues like vector-borne diseases. She shares updates about the global One Health movement with audiences around the world and seeks to connect One Health stakeholders into Action Teams, strategic networks and partnerships that educate about the full scope of and critical need for One Health thinking and acting at all levels of academia, research, clinical practice and government. She refers to One Health as our ‘Ray of Hope for the Future’. |
| | | |
− | ==== Dr Vett Lloyd ==== | + | ====Dr Vett Lloyd==== |
| ''Professor of Biology – Mount Allison University, Canada'' | | ''Professor of Biology – Mount Allison University, Canada'' |
| | | |
| Dr. Vett Lloyd is a professor of Biology at Mount Allison University with expertise in molecular genetics and epigenetics. Her research has included finding animal models for rare human genetic diseases, cloning organisms and cancer cell biology. For the past decade her lab has been working on the genetics of ticks and the pathogens they transmit. Dr. Lloyd is the founding member of the Maritime Lyme Disease Network and Canadian Lyme Consortium, an interdisciplinary network of researchers tackling the biological, social and human dimensions of Lyme disease and incorporating the Lyme patient community as full partners in this endeavor. Dr. Lloyd runs the Mount Allison tick lab, which does tick research that provides tick identification and pathogen testing to members of the public and veterinary medical community in the Maritimes. Her published work in this area includes tick genetics, tick behaviour and the use of dogs as a sentinel species to predict the risk of Lyme disease in humans. Additionally, she has a special interest in encouraging citizen science in tick surveillance activities as a way to promote tick education to communities. | | Dr. Vett Lloyd is a professor of Biology at Mount Allison University with expertise in molecular genetics and epigenetics. Her research has included finding animal models for rare human genetic diseases, cloning organisms and cancer cell biology. For the past decade her lab has been working on the genetics of ticks and the pathogens they transmit. Dr. Lloyd is the founding member of the Maritime Lyme Disease Network and Canadian Lyme Consortium, an interdisciplinary network of researchers tackling the biological, social and human dimensions of Lyme disease and incorporating the Lyme patient community as full partners in this endeavor. Dr. Lloyd runs the Mount Allison tick lab, which does tick research that provides tick identification and pathogen testing to members of the public and veterinary medical community in the Maritimes. Her published work in this area includes tick genetics, tick behaviour and the use of dogs as a sentinel species to predict the risk of Lyme disease in humans. Additionally, she has a special interest in encouraging citizen science in tick surveillance activities as a way to promote tick education to communities. |
| | | |
− | ==== Dr Karl Morten ==== | + | ====Dr Karl Morten==== |
| ''Principal Investigator and Director of Graduate Studies in the Nuffield Department of Women’s and Reproductive Health.'' | | ''Principal Investigator and Director of Graduate Studies in the Nuffield Department of Women’s and Reproductive Health.'' |
| | | |
| The Morten lab has a long standing interest in understanding the role of mitochondria in health and disease and have built up over the last 10 years technologies allowing this to be studied in a high throughput format. As the leading group in Oxford working on mitochondria the group collaborate widely in Oxford, leading to numerous publications in this area. Recently we have been actively exploring the mechanisms behind Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) (https://www.mortengroup.org.uk/) in addition to developing new approaches to study cancer energetics in a project funded by Horizon 2020. | | The Morten lab has a long standing interest in understanding the role of mitochondria in health and disease and have built up over the last 10 years technologies allowing this to be studied in a high throughput format. As the leading group in Oxford working on mitochondria the group collaborate widely in Oxford, leading to numerous publications in this area. Recently we have been actively exploring the mechanisms behind Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) (https://www.mortengroup.org.uk/) in addition to developing new approaches to study cancer energetics in a project funded by Horizon 2020. |
| | | |
− | ==== Dr Bruno B. Chomel (DVM, MS, PhD, Dr. Sc) ==== | + | ====Dr Bruno B. Chomel (DVM, MS, PhD, Dr. Sc)==== |
| Dr. Chomel graduated from the School of Veterinary Medicine in Lyon, France in 1977 and received his DVM degree in 1978 from the University of Lyon, France. He was a faculty member of the Lyon Veterinary School from 1979 until 1990. Dr. Chomel received a MS in Microbiology (Pasteur Institute, Paris, 1981), a MS in Immunology (University of Lyon, 1982) and his PhD in Microbiology (1984), as well as his research directorship degree (former Dr.Sc degree) in 1989 from the same University. He served for 2 years as an Epidemic Intelligence Service Officer for the Centers for Disease control in Atlanta. Dr. Chomel served as a consultant in several international organizations including the French Ministry of Foreign Affairs, the United Nations Development Program, the World Health Organization, the World Bank, and NGOs such as Bioforce and Vétérinaires sans Frontières. Dr. Chomel joined the faculty of the School of Veterinary Medicine, UC Davis in 1990 where he is Professor of Zoonoses since 1999 and was nominated distinguished Professor in 2018. His research centers on cat scratch disease and Bartonella infections in domestic animals and wildlife, the epidemiology of rabies and plague and zoonoses of wildlife. He has authored or co-authored more than 220 peer-reviewed publications and numerous book chapters. He was the Director of the World Health Organization/Pan American Health Organization (WHO/PAHO) Collaborating Center on New and Emerging Zoonoses from 1997 until 2009 and was the Director of the Master of Preventive Veterinary Medicine at UC-Davis from 1998 until 2001 and from 2008 until 2013. Dr. Chomel was elected corresponding member of the French National Academy of Medicine in January 2007. | | Dr. Chomel graduated from the School of Veterinary Medicine in Lyon, France in 1977 and received his DVM degree in 1978 from the University of Lyon, France. He was a faculty member of the Lyon Veterinary School from 1979 until 1990. Dr. Chomel received a MS in Microbiology (Pasteur Institute, Paris, 1981), a MS in Immunology (University of Lyon, 1982) and his PhD in Microbiology (1984), as well as his research directorship degree (former Dr.Sc degree) in 1989 from the same University. He served for 2 years as an Epidemic Intelligence Service Officer for the Centers for Disease control in Atlanta. Dr. Chomel served as a consultant in several international organizations including the French Ministry of Foreign Affairs, the United Nations Development Program, the World Health Organization, the World Bank, and NGOs such as Bioforce and Vétérinaires sans Frontières. Dr. Chomel joined the faculty of the School of Veterinary Medicine, UC Davis in 1990 where he is Professor of Zoonoses since 1999 and was nominated distinguished Professor in 2018. His research centers on cat scratch disease and Bartonella infections in domestic animals and wildlife, the epidemiology of rabies and plague and zoonoses of wildlife. He has authored or co-authored more than 220 peer-reviewed publications and numerous book chapters. He was the Director of the World Health Organization/Pan American Health Organization (WHO/PAHO) Collaborating Center on New and Emerging Zoonoses from 1997 until 2009 and was the Director of the Master of Preventive Veterinary Medicine at UC-Davis from 1998 until 2001 and from 2008 until 2013. Dr. Chomel was elected corresponding member of the French National Academy of Medicine in January 2007. |
| | | |
− | ==== Fred Verdult ==== | + | ====Fred Verdult==== |
| ''Chairman of the Dutch Lyme Patients Association'' | | ''Chairman of the Dutch Lyme Patients Association'' |
| | | |
| In 2018, Fred Verdult received the royal decoration as Knight for his 20 years of commitment to people living with HIV, and in particular for bringing the patient perspective into research on HIV cure. Since 2018 he is chairman of the Dutch Lyme Patients Association, as well as founding father of the Dutch Lyme Fund (Lymefonds). ‘Partly due to the efforts of activists, I now only take one HIV pill per day, and I have never been ill because of HIV at all. The contrast with Lyme couldn’t be greater: my struggle to obtain a diagnosis, the disabling symptoms and my 78 daily pills and drinks.’ | | In 2018, Fred Verdult received the royal decoration as Knight for his 20 years of commitment to people living with HIV, and in particular for bringing the patient perspective into research on HIV cure. Since 2018 he is chairman of the Dutch Lyme Patients Association, as well as founding father of the Dutch Lyme Fund (Lymefonds). ‘Partly due to the efforts of activists, I now only take one HIV pill per day, and I have never been ill because of HIV at all. The contrast with Lyme couldn’t be greater: my struggle to obtain a diagnosis, the disabling symptoms and my 78 daily pills and drinks.’ |
| | | |
− | ==== Dr Willie Weir ==== | + | ====Dr Willie Weir==== |
| ''Senior University Clinician (Veterinary Pathology, Public Health & Disease Investigation)Associate (Institute of Biodiversity Animal Health & Comparative Medicine), University of Glasgow, UK'' | | ''Senior University Clinician (Veterinary Pathology, Public Health & Disease Investigation)Associate (Institute of Biodiversity Animal Health & Comparative Medicine), University of Glasgow, UK'' |
| | | |
| Dr Weir graduated from the University of Glasgow Veterinary School in 1995. After spending five years in mixed practice in the North of England, he returned to Glasgow on a Wellcome Trust Fellowship to study the molecular epidemiology of Cryptosporidium. Following a secondment to the State Veterinary Service to assist with the Foot and Mouth crisis in 2001, Dr Weir accepted a Scholarship from Glasgow Veterinary School to allow him to pursue a PhD in Molecular Parasitology, which he completed in 2006. His research interests have developed in a number of areas including the genetics, genomics and transcriptomics of protozoan parasites, principally Theileria and Babesia. He is Principal Investigator on several projects investigating tick-borne pathogens and is currently funded to pursue research by the Scottish Government, EU, HBLB and the Donkey Sanctuary. In 2016, Dr Weir was appointed as Academic Head of the Veterinary Diagnostic Service Infectious Disease Unit at the University of Glasgow. | | Dr Weir graduated from the University of Glasgow Veterinary School in 1995. After spending five years in mixed practice in the North of England, he returned to Glasgow on a Wellcome Trust Fellowship to study the molecular epidemiology of Cryptosporidium. Following a secondment to the State Veterinary Service to assist with the Foot and Mouth crisis in 2001, Dr Weir accepted a Scholarship from Glasgow Veterinary School to allow him to pursue a PhD in Molecular Parasitology, which he completed in 2006. His research interests have developed in a number of areas including the genetics, genomics and transcriptomics of protozoan parasites, principally Theileria and Babesia. He is Principal Investigator on several projects investigating tick-borne pathogens and is currently funded to pursue research by the Scottish Government, EU, HBLB and the Donkey Sanctuary. In 2016, Dr Weir was appointed as Academic Head of the Veterinary Diagnostic Service Infectious Disease Unit at the University of Glasgow. |
| | | |
− | ==== Michael J Cook ==== | + | ====[[Michael John Cook|Michael J Cook]]==== |
| BSc degree from London University (Physics and Mathematics). His 36 year career included computer chip design, research and development and process engineering in the semiconductor industry. Working in the United Kingdom, United States and leading multinational teams from the US, Europe and Asia. He was diagnosed with Lyme disease in 2009 and started to investigate Lyme and associated diseases. He is author or co-author of 6 papers on Lyme disease and has presented his work at conferences in Paris, Boston, Dublin and London. Other work includes presentations to members of the UK Houses of Lords and Commons, medical and national & local government environmental and health agencies. He also investigated a UK Lyme testing laboratory and provided the evidence of failures in support of patient representations to the UK Parliamentary and Health Services Ombudsman. He also accompanied a team to the United Nations where evidence of regarding human rights abuses related to patients and doctors treating Lyme disease was presented. | | BSc degree from London University (Physics and Mathematics). His 36 year career included computer chip design, research and development and process engineering in the semiconductor industry. Working in the United Kingdom, United States and leading multinational teams from the US, Europe and Asia. He was diagnosed with Lyme disease in 2009 and started to investigate Lyme and associated diseases. He is author or co-author of 6 papers on Lyme disease and has presented his work at conferences in Paris, Boston, Dublin and London. Other work includes presentations to members of the UK Houses of Lords and Commons, medical and national & local government environmental and health agencies. He also investigated a UK Lyme testing laboratory and provided the evidence of failures in support of patient representations to the UK Parliamentary and Health Services Ombudsman. He also accompanied a team to the United Nations where evidence of regarding human rights abuses related to patients and doctors treating Lyme disease was presented. |
| | | |
− | {{(ébauche)}}
| + | ==Références== |
− | | + | <references /> |
− | == Références == | |
− | <references/> | |
| | | |
| {{DEFAULTSORT:Lambert, John Shearer}} | | {{DEFAULTSORT:Lambert, John Shearer}} |